| Drug Name (select from list of drugs shown) |
|
|
| Patient Information |
| Patient Name: |
|
|
| Patient ID: |
|
|
| Patient Group No.: |
|
|
| Patient DOB: |
|
|
| Prescribing Physician |
| Physician Name: |
|
|
| Physician Phone: |
|
|
| Physician Fax: |
|
|
| Physician Address: |
|
|
| City, State, Zip: |
|
|
| Please circle the appropriate answer for each question. |
| 1. |
Has the diagnosis of CF been confirmed by appropriate diagnostic or genetic testing? |
|
|
| |
[If no, then no further questions.] |
|
| 2. |
Is Pseudomonas aeruginosa present in the cultures of the airway? |
|
|
| |
[If no, then no further questions.] |
|
| 3. |
Is the patient currently receiving Cayston? |
|
|
| |
[If no, then no further questions.] |
|
| 4. |
Is the patient younger than 6 years of age? |
|
|
| |
[If yes, then skip to question 6.] |
|
| 5. |
Has the patient's lung function worsened while on Cayston (defined as a decrease in PFTs by greater than 10%)? |
|
|
| |
[If no, then no further questions.] |
|
| 6. |
Is there a clinical reason to continue Cayston therapy (e.g., patient had symptomatic improvement, patient had decreased number of pulmonary infections and/or exacerbations)? |
|
|
I affirm that the information given on this form is true and accurate as of this date.
|